Biotech stocks remain on many investors’ radar and for good reasons. Biotech companies are usually more insulated from global events such as the ongoing COVID-19 pandemic and economic uncertainty.

The company had planned to sell 13.6 million shares in the range of $28 to $31 apiece. The IPO haul was about $500 million. The biotech’s shares will trade on the Nasdaq under the stock symbol ...

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism ...

CEN Biotech, Inc. focuses on the manufacture ... and to provide digital marketing and web design related services. The company was incorporated in 2013 and is based in Windsor, Canada.

The idea is a biotech stock might soar as investors bet on the company's cutting-edge technology through its development stages -- and the stock could continue to gain after that company moves ...

Novo Nordisk looks to harness Septerna’s broader GPCR drug pathways, which include GLP-1, for obesity and diabetes treatments.

Insider buying A less-risky approach to biotech is to invest in large-cap biopharma stocks. These two companies saw corporate insiders recently buying stock. Pfizer Inc. (PFE): Pfizer's size and ...